Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

被引：0
|
作者：
Acar, Ibrahim Halil [1 ]
Atalay, Figen [2 ]
Demirsoy, Esra Terzi [3 ]
Can, Ferda [4 ]
Guven, Zeynep Tugba [5 ]
Cetiner, Mustafa [6 ]
Tombak, Anil [7 ]
Comert, Melda [8 ]
Guvenc, Birol [1 ]
机构：
[1] Cukurova Univ, Dept Hematol, Dept Internal Med, Fac Med, Adana, Turkiye
[2] Baskent Univ, Istanbul Hosp, Hematol Clin, Ankara, Turkiye
[3] SBU Kocaeli Derince Training & Res Hosp, Hematol Clin, Kocaeli, Turkiye
[4] Ankara City Hosp, Hematol Clin, Ankara, Turkiye
[5] Erciyes Univ, Dept Hematol, Dept Internal Med, Fac Med, Kayseri, Turkiye
[6] Acibadem Maslak Hosp, Hematol Clin, Istanbul, Turkiye
[7] Mersin Univ, Dept Hematol, Dept Internal Med, Fac Med, Mersin, Turkiye
[8] SBU Gulhane Training & Res Hosp, Hematol Clin, Istanbul, Turkiye
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
MDS; myelodysplastic syndrome; darbepoetin alfa;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDS-143
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [1] Darbepoetin alfa for anemia with myelodysplastic syndrome
    Seastone, David J.
    Gerds, Aaron T.
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) : 139 - 146
  • [2] A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
    Schwartzberg, L
    Shiffman, R
    Tomita, D
    Stolshek, B
    Rossi, G
    Adamson, R
    CLINICAL THERAPEUTICS, 2003, 25 (11) : 2781 - 2796
  • [3] The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study
    Muzeyyen Aslaner Ak
    Birsen Sahip
    Ayfer Geduk
    Mehmer Ali Ucar
    Hacer Kale
    Tugba Hacibekiroglu
    Merve Gokcen Polat
    Yasin Kalpakci
    Ali Zahit Bolaman
    Birol Guvenc
    Sehmus Ertop
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 299 - 308
  • [4] The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study
    Ak, Muzeyyen Aslaner
    Sahip, Birsen
    Geduk, Ayfer
    Ucar, Mehmer Ali
    Kale, Hacer
    Hacibekiroglu, Tugba
    Polat, Merve Gokcen
    Kalpakci, Yasin
    Bolaman, Ali Zahit
    Guvenc, Birol
    Ertop, Sehmus
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (02) : 299 - 308
  • [5] Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice
    Patton, J
    Reeves, T
    Wallace, J
    ONCOLOGIST, 2004, 9 (04) : 451 - 458
  • [6] Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan
    Hattori, Motoshi
    Matsunaga, Akira
    Akioka, Yuko
    Fujinaga, Shuichiro
    Nagai, Takuhito
    Uemura, Osamu
    Nakakura, Hyogo
    Ashida, Akira
    Kamei, Koichi
    Ito, Shuichi
    Yamada, Takuji
    Goto, Yoshimitsu
    Ohta, Toshiyuki
    Hisano, Masataka
    Komatsu, Yasuhiro
    Itami, Noritomo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (04) : 582 - 588
  • [7] Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan
    Motoshi Hattori
    Akira Matsunaga
    Yuko Akioka
    Shuichiro Fujinaga
    Takuhito Nagai
    Osamu Uemura
    Hyogo Nakakura
    Akira Ashida
    Koichi Kamei
    Shuichi Ito
    Takuji Yamada
    Yoshimitsu Goto
    Toshiyuki Ohta
    Masataka Hisano
    Yasuhiro Komatsu
    Noritomo Itami
    Clinical and Experimental Nephrology, 2013, 17 : 582 - 588
  • [8] A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia
    Justice, G
    Kessler, JF
    Jadeja, J
    Campos, L
    Weick, J
    Chen, CF
    Heatherington, AC
    Amado, RG
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1192 - 1198
  • [9] Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan
    Motoshi Hattori
    Osamu Uemura
    Hiroshi Hataya
    Shuichi Ito
    Masataka Hisano
    Toshiyuki Ohta
    Shuichiro Fujinaga
    Tomoo Kise
    Yoshimitsu Gotoh
    Akira Matsunaga
    Naoko Ito
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2014, 18 : 634 - 641
  • [10] Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan
    Hattori, Motoshi
    Uemura, Osamu
    Hataya, Hiroshi
    Ito, Shuichi
    Hisano, Masataka
    Ohta, Toshiyuki
    Fujinaga, Shuichiro
    Kise, Tomoo
    Gotoh, Yoshimitsu
    Matsunaga, Akira
    Ito, Naoko
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (04) : 634 - 641
12345